Drug delivery from injectable calcium phosphate foams by tailoring the macroporosity-drug interaction

Acta Biomaterialia

Volumn 12, Issue 1, 2015, Pages 250-259

  Pastorino, David ^a   Canal, Cristina ^a   Ginebra, Maria Pau ^a  

^a NONE

Author keywords

Calcium phosphate cement; Controlled release; Drug delivery; Foam; Scaffold

Indexed keywords

ADHESION; ANTIBIOTICS; CEMENTS; CONTROLLED DRUG DELIVERY; DRUG DOSAGE; DRUG INTERACTIONS; ESCHERICHIA COLI; HYDROXYAPATITE; SCAFFOLDS; TARGETED DRUG DELIVERY;

BONE REGENERATION; CALCIUM PHOSPHATE CEMENT; CONTROLLED RELEASE; DOSAGE FORMS; DOXYCYCLINE; DRUG RELEASE; INJECTABLES; MACRO-POROSITY; MATERIALS STRUCTURE; RELEASE PROFILES;

CALCIUM PHOSPHATE;

CALCIUM PHOSPHATE; CEMENT; DOXYCYCLINE HYCLATE; HYDROXYAPATITE; ANTIINFECTIVE AGENT; DOXYCYCLINE; DRUG CARRIER;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BONE CONDUCTION; BONE REGENERATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG RELEASE; ESCHERICHIA COLI; FOAM; MODEL; NON FICKIAN DIFFUSION MODEL; OSTEOLYSIS; PASTE; POROSITY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; SURFACE TENSION; DRUG EFFECTS; DRUG INTERACTION; MICROBIAL SENSITIVITY TEST;

ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CALCIUM PHOSPHATES; DOXYCYCLINE; DRUG CARRIERS; DRUG INTERACTIONS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; POROSITY; STAPHYLOCOCCUS AUREUS;

EID: 84925041277     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.10.031     Document Type: Article

References (41)

1. Dorozhkin SV. Calcium orthophosphate cements for biomedical application. J Mater Sci 2008;43:3028-57.
2. Ginebra M-P, Traykova T, Planell JA. Calcium phosphate cements as bone drug delivery systems: a review. J Control Release 2006;113:102-10.
3. Ginebra M-P, Traykova T, Planell JA. Calcium phosphate cements: competitive drug carriers for the musculoskeletal system? Biomaterials 2006;27:2171-7.
4. Espanol M, Perez RA, Montufar EB, Marichal C, Sacco A, Ginebra M-P. Intrinsic porosity of calcium phosphate cements and its significance for drug delivery and tissue engineering applications. Acta Biomater 2009;5:2752-62.
5. Verron E, Khairoun I, Guicheux J, Bouler J-M. Calcium phosphate biomaterials as bone drug delivery systems: a review. Drug Discov Today 2010;15:547-52.
6. Ginebra M-P, Canal C, Espanol M, Pastorino D, Montufar EB. Calcium phosphate cements as drug delivery materials. Adv Drug Deliv Rev 2012;64:1090-110.
7. Otsuki B, Takemoto M, Fujibayashi S, Neo M, Kokubo T, Nakamura T. Pore throat size and connectivity determine bone and tissue ingrowth into porous implants: three-dimensional micro-CT based structural analyses of porous bioactive titanium implants. Biomaterials 2006;27:5892-900.
8. Canal C, Pastorino D, Mestres G, Schuler P, Ginebra M-P. Relevance of microstructure for the early antibiotic release of fresh and pre-set calcium phosphate cements. Acta Biomater 2013;9:8403-12.
9. Tsourvakas S. Local antibiotic therapy in the treatment of bone and soft tissue infections. In: Danilla S, editor. Selected topics in plastic reconstructive surgery. InTech, Open Access; 2012. p. 17-44.
10. Habraken WJEM, Wolke JGC, Jansen JA. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59:234-48.
11. Montufar EB, Traykova T, Gil C, Harr I, Almirall A, Aguirre A, et al. Foamed surfactant solution as a template for self-setting injectable hydroxyapatite scaffolds for bone regeneration. Acta Biomater 2010;6:876-85.
12. Montufar EB, Traykova T, Planell JA, Ginebra M-P. Comparison of a low molecular weight and a macromolecular surfactant as foaming agents for injectable self setting hydroxyapatite foams: polysorbate 80 versus gelatine. Mater Sci Eng C 2011;31:1498-504.
13. Ginebra M-P, Delgado J-A, Harr I, Almirall A, Del Valle S, Planell JA. Factors affecting the structure and properties of an injectable self-setting calcium phosphate foam. J Biomed Mater Res A 2007;80:351-61.
14. Saint-Jalmes A, Peugeot M-L, Ferraz H, Langevin D. Differences between protein and surfactant foams: microscopic properties, stability and coarsening. Colloids Surf A Physicochem Eng Aspects 2005;263:219-25.
15. Pountos I, Georgouli T, Bird H, Kontakis G, Giannoudis PV. The effect of antibiotics on bone healing: current evidence. Expert Opin Drug Saf 2011;10:935-45.
16. Kallala R, Graham SM, Nikkhah D, Kyrkos M, Heliotis M, Mantalaris A, et al. In vitro and in vivo effects of antibiotics on bone cell metabolism and fracture healing. Expert Opin Drug Saf 2012;11:15-32.
17. Ong SM, Taylor GJS. Doxycycline inhibits bone resorption by human interface membrane cells from aseptically loose hip replacements. J Bone Joint Surg Br 2003;85:456-61.
18. Preshaw PM, Hefti AF, Jepsen S, Etienne D, Walker C, Bradshaw MH. Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review. J Clin Periodontol 2004;31:697-707.
19. Job-Deslandre C, Krebs S, Kahan A. Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases. Joint Bone Spine 2001;68:245-51.
20. Roeder B, Van Gils CC, Maling S. Antibiotic beads in the treatment of diabetic pedal osteomyelitis. J Foot Ankle Surg 2000;39:124-30.
21. Bartkowski SB, Zapala J, Heczko P, Szuta M. Actinomycotic osteomyelitis of the mandible: review of 15 cases. J Cranio-Maxillo-Facial Surg 1998;26:63-7.
22. Thompson S, Townsend R. Pharmacological agents for soft tissue and bone infected with MRSA: which agent and for how long? Injury 2011;42(Suppl. 5):S7-S10.
23. Bohner M, Baroud G. Injectability of calcium phosphate pastes. Biomaterials 2005;26:1553-63.
24. Montufar EB, Maazouz Y, Ginebra MP. Relevance of the setting reaction to the injectability of tricalcium phosphate pastes. Acta Biomater 2013;9:6188-98.
25. Almirall A, Larrecq G, Delgado J. Fabrication of low temperature macroporous hydroxyapatite scaffolds by foaming and hydrolysis of an α-TCP paste. Biomaterials 2004;25:3671-80.
26. United States Pharmacopeia and National Formulary. Dissolution. Rockville, MD: US Pharmacopeial Convention; 2008. p. 267-274.
27. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-6.
28. Mastrogiacomo M, Scaglione S, Martinetti R, Dolcini L, Beltrame F, Cancedda R, et al. Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate bioceramics. Biomaterials 2006;27:3230-7.
29. Ding X, Alani A, Robinson J. Remington. The science and practice of pharmacy. In: Hendrickson R, editor. Remington science and practice of pharmacy. Groningen: Lippincott Williams & Wilkins; 2006. p. 939-64.
30. Geurts J, Chris Arts JJ, Walenkamp GHIM. Bone graft substitutes in active or suspected infection. Contra-indicated or not? Injury 2011;42(Suppl. 2):S82-6.
31. Siepmann J, Peppas NA. Higuchi equation: derivation, applications, use and misuse. Int J Pharm 2011;418:6-12.
32. Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1987;5:23-36.
33. Liu W, Chang J. In vitro evaluation of gentamicin release from a bioactive tricalcium silicate bone cement. Mater Sci Eng C 2009;29:2486-92.
34. Kisanuki O, Yajima H, Umeda T, Takakura Y. Experimental study of calcium phosphate cement impregnated with dideoxy-kanamycin B. J Orthop Sci 2007;12:281-8.
35. Takechi M, Miyamoto Y, Ishikawa K, Nagayama M, Kon M, Asaoka K, et al. Effects of added antibiotics on the basic properties of anti-washout-type fast-setting calcium phosphate cement. J Biomed Mater Res 1998;39:308-16.
36. Vorndran E, Geffers M, Ewald A, Lemm M, Nies B, Gbureck U. Ready-to-use injectable calcium phosphate bone cement paste as drug carrier. Acta Biomater 2013;9:9558-67.
37. Alkhraisat MH, Rueda C, Cabrejos-Azama J, Lucas-Aparicio J, Mariño FT, Torres García-Denche J, et al. Loading and release of doxycycline hyclate from strontium-substituted calcium phosphate cement. Acta Biomater 2010;6:1522-8.
38. David Chen C-H, Chen C-C, Shie M-Y, Huang C-H, Ding S-J. Controlled release of gentamicin from calcium phosphate/alginate bone cement. Mater Sci Eng C 2011;31:334-41.
39. Schnieders J, Gbureck U, Vorndran E, Schossig M, Kissel T. The effect of porosity on drug release kinetics from vancomycin microsphere/calcium phosphate cement composites. J Biomed Mater Res B Appl Biomater 2011;99:391-8.
40. Bettany JT, Peet NM, Wolowacz RG, Skerry TM, Grabowski PS. Tetracyclines induce apoptosis in osteoclasts. Bone 2000;27:75-80.
41. Del Valle S, Mino N, Munoz F, Gonzalez A, Planell JA, Ginebra MP. In vivo evaluation of an injectable macroporous calcium phosphate cement. J Mater Sci - Mater Med 2007;18:353-61.